Neurology / Neuroscience News From Medical News Today ...
View article titles only.
- Memory Problems More Common In Men?
A new study shows that mild cognitive impairment (MCI) may affect more men than women. The research is published in the September 7, 2010, print issue of Neurology®, the medical journal of the American Academy of Neurology. Mild cognitive impairment is a condition in which people have problems with memory or thinking beyond that explained by the normal rate of aging... - Scientists Decode Words From Brain Signals
In an early step toward letting severely paralyzed people speak with their thoughts, University of Utah researchers translated brain signals into words using two grids of 16 microelectrodes implanted beneath the skull but atop the brain... - Men Are More Likely To Develop Mild Cognitive Impairment Than Women - Alzheimer's Society Comment
Mild cognitive impairment (MCI) may affect more men than women research published in the journal Neurology claims. The study of 2,050 people aged 70-89 living in Olmstead County, Minnesota found MCI was 1.5 times higher in men than women with 19 percent of men having MCI compared to 14 percent of women... - New Model May Simplify High-Dose Radiosurgery Planning
There is yet no straightforward way to determine the optimal dose level and treatment schedules for high-dose radiation therapies such as stereotactic radiation therapy, which is used to treat brain and lung cancer, or for high-dose brachytherapy for prostate and other cancers. Radiation oncologists at the Ohio State University Comprehensive Cancer Center-Arthur G... - Reports Of Narcolepsy In Europe Following Vaccination With Pandemrix™
GSK initially became aware of possible cases of narcolepsy following vaccination with the adjuvanted H1N1 pandemic vaccine Pandemrix through adverse event reports received by the Swedish Medical Products Agency, and subsequently via media reports in Finland... - BioDelivery Sciences Announces Positive Meeting With FDA On A Streamlined ONSOLIS REMS With Broadened Distribution
BioDelivery Sciences International, Inc. (NASDAQ:BDSI) announced a positive meeting with the U.S. Food and Drug Administration (FDA), Meda and BDSI that occurred on Wednesday, July 21, 2010 to discuss significant modifications to the existing Risk Evaluation and Mitigation Strategy (REMS) program for ONSOLIS (fentanyl buccal soluble film)... - U.S. Neurologists Agree On Protocols For Treatment Of Infantile Spasms
Researchers from across the U.S., as part of the Infantile Spasms Working Group (ISWG), established guidelines for the diagnosis and treatment of infantile spasms (IS). The goal of the ISWG is to improve patient outcomes by creating protocols that educate pediatricians on early diagnosis and treatment options... - All Genes In One Go
The majority of rare diseases are hereditary. But despite significant progress in genome research, in most cases their exact cause remains unclear. The discovery of the underlying genetic defect is, however, a prerequisite for their definitive diagnosis and the development of innovative approaches to their treatment... - Rochester Leads International Effort To Improve Muscular Dystrophy Treatment
A large international study aimed at improving the care of muscular dystrophy patients worldwide is being launched by physicians, physical therapists, and researchers at the University of Rochester Medical Center. Neurologist Robert "Berch" Griggs, M.D., is heading the study of treatments for Duchenne muscular dystrophy, the most common form of the disease that affects children... - What's Causing Life-Threatening Blood Clots Following Brain Surgery?
One of the most severe complications of brain surgery is a life-threatening blood clot in the lungs called a pulmonary embolism. But a Loyola University Health System study published in the Journal of Neurosurgery suggests that screening methods hospitals typically use to access the risk of pulmonary embolisms may fall short... - Functional Motor Neuron Subtypes Generated From Embryonic Stem Cells
Scientists have devised a method for coaxing mouse embryonic stem cells into forming a highly specific motor neuron subtype. The research, published by Cell Press in the September 3rd issue of the journal Cell Stem Cell, provides new insight into motor neuron differentiation and may prove useful for devising and testing future therapies for motor neuron diseases... - Scientists Uncover Counterpart Of Cerebral Cortex In Marine Worms
Our cerebral cortex, or pallium, is a big part of what makes us human: art, literature and science would not exist had this most fascinating part of our brain not emerged in some less intelligent ancestor in prehistoric times... - Moussa B.H. Youdim Wins The 2010 ECNP Lifetime Achievement Award
Award presentation at the 23rd Congress of the European College of Neuropsychopharmacology in Amsterdam, The Netherlands The European College of Neuropsychopharmacology (ECNP) is pleased to announce Moussa B. H... - Cancer Drug Model Could Be A Potential Treatment For Alzheimer's - Alzheimer's Society Comment
Treatments modelled on the cancer drug Gleevec could potentially prevent the formation of amyloid plaques - one of the major hallmarks of Alzheimer's disease according to a study. Treatments modelled on the cancer drug Gleevec could potentially prevent the formation of amyloid plaques - one of the major hallmarks of Alzheimer's disease according to a study published in the journal Nature... - Most Neurologists Plan To Prescribe Oral Multiple Sclerosis Drugs, But Will Proceed With Caution
In a study published this week by Majestic Research, almost 60% of neurologists expressed unaided concern about the side effects/safety of oral MS therapies in development, including NVS's Gilenia and MRK/EMD Serono's oral cladribine... - In A Rat Model Of Stroke, Protecting Nerve Cells From Death
A team of researchers, led by Yizheng Wang, at the Chinese Academy of Sciences, China, has identified a way to preserve nerve cells in a rat model of stroke. Stroke is most commonly caused by impaired delivery of oxygen to part of the brain as a result of disruption to the blood supply (a condition known as ischemia)... - Eisai Announces The Start Of The First Clinical Study Of Ban2401, A Novel Monoclonal Antibody Targeting Neurotoxic Protofibrils
Eisai Co., Ltd. (Headquarters: Tokyo, Japan, President & CEO: Haruo Naito, "Eisai") announced today the start of the first patient enrolled clinical study with BAN2401, a novel monoclonal antibody that is being developed as a potential next-generation therapeutic treatment for Alzheimer's disease... - Proprietary Zinc/Phytase Formulation Improved Botulinum Toxin A Results
A recent study conducted by oculoplastic surgeon Charles Soparkar, M.D., Ph.D. (The Methodist Hospital, Houston, TX) utilizing a patent-pending formulation of zinc and phytase (trademarked as ZYTAZE™), demonstrated that increasing zinc levels by oral administration for 4 days prior to a planned injection of botulinum toxin improved efficacy and/or duration in 41 of 44 patients tested (93%)... - Infant's Gaze May Be An Early, But Subtle, Marker For Autism Risk
Kennedy Krieger Institute announced new study results showing an early marker for later communication and social delays in infants at a higher-risk for autism may be infrequent gazing at other people when unprompted... - ReVision's Fenretinide (RT-101) Reduced Incidence Of Choroidal Neovascularization By More Than 50 Percent In Patients With Geographic Atrophy
ReVision Therapeutics Inc. announced that data from a Phase 2b trial show that fenretinide (RT-101) reduced the incidence of choroidal neovascularization (CNV, wet age related macular degeneration) by about 50 percent in patients with geographic atrophy (GA), the most advanced form of dry age related macular degeneration (AMD). The data, presented Monday by Alexander M. Eaton, M.D... - New Light On The Mechanism Of Parkinson's Disease
A significant number of Parkinson's disease patients have a mutation of the enzyme Leucine-Rich Repeat Protein Kinase 2 (LRRK2, also known as dardarin). However, little is understood about how it is regulated or functions... - Fisher Scientists Discover Protein That Fuels Alzheimer's Disease, Promising New Treatments Expected
Researchers at the Fisher Center for Alzheimer's Disease Research laboratory published "Gamma-secretase Activating Protein is a Therapeutic Target for Alzheimer's Disease" in Nature online. Drs. Gen He (lead author) and Paul Greengard have discovered a protein that stimulates the production of beta-amyloid, and therefore represents a major new advance in Alzheimer's disease research... - Donation By Author J K Rowling Aids Multiple Sclerosis Research In The UK
A research clinic for multiple sclerosis patients is being set up with a 10 million pound donation from the author J K Rowling. The Anne Rowling Regenerative Neurology Clinic at the University of Edinburgh will place patients at the heart of research to improve outcomes for multiple sclerosis sufferers... - Brain Exercises May Slow Cognitive Decline Initially, But Speed Up Dementia Later
New research shows that mentally stimulating activities such as crossword puzzles, reading and listening to the radio may, at first, slow the decline of thinking skills but speed up dementia later in old age. The research is published in the September 1, 2010, online issue of Neurology®, the medical journal of the American Academy of Neurology... - Mental Stimulation Delays The Decline In Thinking Skills, But May Accelerate Dementia Later On
Mentally stimulating activities that challenge and engage the brain, such as crossword puzzles, reading, or listening to the radio may help slow down cognitive decline - the gradual deterioration of thinking skills - but may encourage the acceleration of dementia later on during old age, says a report in Neurology, the journal of the American Academy of Neurology. Study author, Robert S...